We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.


Research activities

HPV Primary Screening Project

The Manchester Cytology Centre is one of the six national sentinel sites currently working with the national office of the NHSCSP to introduce HPV testing as the primary screening test within the cervical screening programme. Approximately 40% of the laboratory workload from the Cumbria and Lancashire area has been converted to HPV primary screening with the remainder using traditional cytology primary screening.

The Hospital Based Programme Co-ordinator sends data at regular intervals to the national team to inform progress within the pilot study.


The department is one of three sites using CINtec PLUS Cytology® which is an advanced combination of biomarkers that can help identify women who are HPV positive with borderline or low-grade cytological abnormalities that may have underlying high-grade disease.


(Last updated March 30th 2016)